TransCode Therapeutics, Inc. - Common Stock
TransCode Therapeutics, Inc. - Common Stock
Share · US89357L3033 · RNAZ (XNAS)
Overview Financial Indicators
7,50 USD
-1,32 % -0,10 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
10.06.2025 19:59

Current Prices from TransCode Therapeutics, Inc. - Common Stock

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
RNAZ
USD
10.06.2025 19:59
7,50 USD
7,45 USD
+0,67 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 0,27 % -19,63 % -80,85 % -96,83 % -99,37 % -100,00 %

Company Profile for TransCode Therapeutics, Inc. - Common Stock Share

TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1; TTX-siLIN28B, an siRNA-based inhibitor of RNA-binding protein LIN28B. Its cancer agnostic programs comprise TTX-RIGA, an RNA–based agonist of the RIG-I-driven immune response in the tumor microenvironment; TTX-CRISPR, a CRISPR/Cas9–based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells; and TTX-mRNA, an mRNA-based platform for the development of cancer vaccines meant to activate cytotoxic immune responses against tumor cells. The company was incorporated in 2016 and is based in Boston, Massachusetts.

Company Data

Name TransCode Therapeutics, Inc. - Common Stock
Company TransCode Therapeutics, Inc.
Symbol RNAZ
Website https://www.transcodetherapeutics.com
Primary Exchange XNAS NASDAQ
ISIN US89357L3033
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Thomas A. Fitzgerald M.B.A.
Country United States of America
Currency USD
Employees 0,0 T
Address 6 Liberty Square, 02109 Boston
IPO Date 2021-07-08

Stock Splits

Date Split
15.05.2025 1:28
04.12.2024 1:33

Ticker Symbols

Name Symbol
NASDAQ RNAZ

More Shares

Investors who TransCode Therapeutics, Inc. - Common Stock hold also have the following shares in their portfolio:
HOME DEPOT 21/31
HOME DEPOT 21/31 Bond
LYXOR IBOXX $ LIQUID EMERGING MARKETS SOVEREIGNS UCITS ETF - DIST
LYXOR IBOXX $ LIQUID EMERGING MARKETS SOVEREIGNS UCITS ETF - DIST ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025